In order to create the optimal political, economic and social environment for the biotechnology sector to develop, we have to join forces.
The collaboration agreements we have signed with national and international organizations allow us to promote, among other activities, analysis of the ecosystem, in the AseBio Report; joint proposals submitted to political and economic authorities to bring about changes that benefit the sector; the internationalization of our companies; and scientific dissemination.
Created under the initiative of the Spanish Society of Medical Oncology (SEOM), ASEICA was set up to promote research and innovation as the main tool to improve the survival and quality of life of cancer patients.
AseBio has adhered to the Manifesto published by this association, which seeks a commitment from the Government to invest in science and technology, among other issues.
We have established a collaboration agreement between AEAC and AseBio with the aim of disseminating and supporting the action strategy of this Association, which focuses on working on the relationship between science and society, facilitating a two-way immersion process.
The Spanish Association of Biocompanies (AseBio) collaborates with the Digital Health Association (ASD) to explore the intersection between new digital technologies and biotechnology, as well as to promote dissemination and training activities on the possibilities that new digital technologies offer for advances in biotechnology and for tackling the major challenges on the public agenda.
We have a collaboration agreement for carrying out activities of interest to the biotechnology sector and for the mutual dissemination of activities carried out by the two entities. The agreement also allows companies associated with Bioval to benefit from preferential conditions to join AseBio.
We have a collaboration agreement with CEPREDE for the use of data from the INE's biotechnology use module survey, which enables the annual elaboration of the main economic indicators of the biotechnology sector in Spain.
Almost 200 organisations participate in this independent citizens' initiative that aims to make science and scientific knowledge one of the sources of information in the formulation of policy proposals.
#ScienceinParliament aims to promote a political culture close to science and to foster scientific activity focused on the needs of society and, to this end, seeks to import to Spain models of independent scientific advice similar to the existing parliamentary offices in neighbouring countries.
We have established an agreement with the specialised consultancy Clarke, Modet & Cº to obtain data on biotechnology patent applications and grants for use in AseBio's annual report.
We have been a member of the CEOE since 2002, which allows us to have a seat on the Board of Directors of this organisation and to participate in the sectoral Working Committees organised to discuss issues of general interest to the business sector.
AseBio, represented by its general director, forms part of the VHIR Business Council, which advises the management and the Board of Trustees of this research institute, one of the most prominent in the country.
This council, chaired by the businessman Lluís Bassat, also includes representatives from Fenin, CataloniaBIO & HealthTech, Specipig, Grup Ferrer, Fundació Bancària la Caixa, Ametic, Mondragon Health, Roche Diagnostics, Banco Sabadell, Laboratorios Esteve and Biocat, and its mission is to collaborate in the detection of sectorial needs, participate in joint projects and facilitate the Institute's access to public and private resources.
EBD Group and AseBio have established a global partnership agreement that allows us to negotiate advantageous conditions each year for our partners who wish to participate in the major international partnering events organised by AseBio, which are among the most important in the world.
AseBio is part of the EOI Friends of EOI Programme. This programme facilitates access to training for AseBio's members, and member companies will receive a 30% discount on EOI's training programmes, thus providing them with a great advantage and contributing to their growth and improvement.
AseBio is a member of the European biotechnology association Europabio, a body that defends the interests of the sector from its offices in Brussels. Belonging to this institution allows AseBio to participate in the quarterly meetings that bring together representatives of partner associations from all over Europe.
These meetings of the National Associations Council (NAC) complement our participation in various sectoral councils where we discuss strategy on issues of interest to the sector across the continent.
Collaboration agreement with Euro-Funding, a company specialising in the provision of professional consultancy services in the field of European funding, to provide AseBio and its members with an information and alert service on public funding for R&D&I in Europe.
AseBio and the magazine Farmabiotec have signed a collaboration agreement by which this magazine, specialised in biotechnology applied to health, becomes the association's new disseminating body.
The collaboration agreement with FECYT facilitates the exchange and dissemination of bibliometric data on scientific publications related to biotechnology.
The Spanish Federation of Biotechnologists (FEBiotec) and AseBio agree to collaborate in order to promote and disseminate Biotechnology. Both parties consider it advisable to carry out activities of common interest.
The Spanish Generic Medicines Association (AESEG), the Association for Self-Care in Health (anefp), the Spanish Biosimilars Association (BioSim), Farmaindustria, Fenin and AseBio set up this forum in 2017 with the aim of strengthening collaboration with the Administration and promoting solutions that contribute to the development of medicines and health products.
The forum meets periodically to make joint proposals to the Administration to improve healthcare from the perspective of quality and sustainability. The Biomedical Industries Forum is oriented towards debate, prospective analysis and the channelling of ideas and projects that are useful for the Administration and for society as a whole.
A collaboration agreement has been established with the Academy for the development of scientific projects and activities in training activities together with the Societat Catalana de Biotecnologia Mèdica.
The agreement also includes the creation of a grant for research in medical biotechnology, the dissemination of the services that AseBio can offer to the directors of the foundation's research projects and the carrying out of various activities.
Since 2008, AseBio has been managing ICEX's annual Internationalisation Plan for the biotechnology sector. The sectoral plans include coordinated internationalisation activities for a specific sector towards one or several markets, which aim to directly favour the participating companies or indirectly favour the sector as a whole.
The collaborating entities recognised by the Secretary of State for Trade are also recognised by ICEX through the signing of a collaboration agreement.
INE and AseBio have established an agreement to exchange knowledge and experience between the two institutions in order to optimise the production of statistics on the use of biotechnology in the business sector.
AseBio and the Japan Bioindustry Association (our Japanese counterpart) have signed a Memorandum of Understanding whose objectives are to create an agenda with strategic areas of common interest, maximise the benefits for the members of both associations, utilise the networks of contacts of both organisations, integrate activities, and share ideas and knowledge.
Cooperation in the preparation and dissemination of monographs, studies, Technology Watch Bulletins and reports on specific topics considered to be of interest to Spanish companies, foundations and associations. Specifically, quarterly preparation of the Biotechnology Watch Bulletin on a selection of the latest biotechnology patents published in the world, relating to four specific lines of research:
- Nervous System
- Immune System
- Macular Degeneration
In addition, the collaboration establishes cooperation to raise awareness of the Industrial Property protection system, as well as to establish a direct mechanism for resolving doubts with IP managers and the organisation of training sessions.
We have a collaboration agreement with the Madrid Science Park so that companies associated with the PCM can benefit from preferential conditions to join AseBio. On the other hand, we collaborate with the PCM in the exploitation of industrial property data for our annual report.
RAICEX and AseBio collaborate to promote initiatives that facilitate the attraction and promotion of the talent of Spanish scientists abroad.
AseBio is a protective member of the Spanish Society of Biotechnology (Sebiot), AseBio's sister scientific society whose aim is to promote the development of biotechnology in all its branches and activities in Spain.
AseBio and Sebiot share goals and objectives and collaborate on joint projects, especially those aimed at promoting cooperation between researchers and companies, as well as activities to disseminate knowledge of biotechnology to society.
AseBio is recognised as a Collaborating Entity of the Secretary of State for Trade of the Ministry of Industry, Trade and Tourism as an Exporters' Association.
The activities carried out by exporters' associations make an effective contribution to maintaining the presence of Spanish products abroad, enabling them to access new markets. The association is thus entitled to apply for the aid scheme provided for in the regulations in force.
In 2019, AseBio and the Taiwan European Biotech Association have signed a collaboration agreement that will allow them to join forces to promote contacts and joint projects of their respective networks. The Taiwan European Biotech Association brings together international pharmaceutical professionals working in Europe who have their roots in Taiwan.
Taiwan's special economic and legal conditions make it a gateway to China. In addition, its openness to Europe and its habitual fluency in both Mandarin and English make the country an ideal launching pad for Spanish biotech companies in Asian markets.
AseBio and the Virginia Beach Department of Economic Development in the United States have a collaboration agreement (Memorandum of Understanding) whose main objective is to facilitate the establishment in Virginia Beach of interested Spanish biotech companies.
This city has a bioincubator, which offers advantageous conditions from a fiscal and legal point of view for biotech companies wishing to set up there.